ZA200702227B - Combination comprising ZD6474 and imatinib - Google Patents

Combination comprising ZD6474 and imatinib

Info

Publication number
ZA200702227B
ZA200702227B ZA200702227A ZA200702227A ZA200702227B ZA 200702227 B ZA200702227 B ZA 200702227B ZA 200702227 A ZA200702227 A ZA 200702227A ZA 200702227 A ZA200702227 A ZA 200702227A ZA 200702227 B ZA200702227 B ZA 200702227B
Authority
ZA
South Africa
Prior art keywords
imatinib
combination
Prior art date
Application number
ZA200702227A
Inventor
Wedge Stephen Robert
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200702227B publication Critical patent/ZA200702227B/en

Links

ZA200702227A 2004-09-27 2007-03-16 Combination comprising ZD6474 and imatinib ZA200702227B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0421438A GB0421438D0 (en) 2004-09-27 2004-09-27 Combination therapy

Publications (1)

Publication Number Publication Date
ZA200702227B true ZA200702227B (en) 2008-10-29

Family

ID=33397325

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702227A ZA200702227B (en) 2004-09-27 2007-03-16 Combination comprising ZD6474 and imatinib

Country Status (3)

Country Link
CN (1) CN101027059B (en)
GB (1) GB0421438D0 (en)
ZA (1) ZA200702227B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101386697B1 (en) * 2012-06-18 2014-04-18 아주대학교산학협력단 Composition for preventing or treating vascular permeability disease comprising imatinib or pharmaceutically acceptable salts thereof as active ingredient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02004366A (en) * 1999-11-05 2002-11-07 Astrazeneca Ab Quinazoline derivatives as vegf inhibitors.

Also Published As

Publication number Publication date
CN101027059A (en) 2007-08-29
GB0421438D0 (en) 2004-10-27
CN101027059B (en) 2011-07-27

Similar Documents

Publication Publication Date Title
IL181609A0 (en) Combination comprising zd6474 and imatinib
EP1802588A4 (en) Substituted amino-pyrimidones and uses thereof
IL181670A0 (en) Substituted phenylaminothiazoles and use thereof
EP1831170A4 (en) Substituted aminopyridines and uses thereof
EP1756041A4 (en) Polycationic compounds and uses thereof
HK1101911A1 (en) Tetrahydrocarbozoles and derivatives
IL179497A0 (en) Carboranylporphyrins and uses thereof
EP1789409A4 (en) Sulfonamides and uses thereof
EP1824467A4 (en) Apogossypolone and the uses thereof
GB2435936B (en) Combination square
ZA200704295B (en) Arthrospira-based compositions and uses thereof
EP1737458A4 (en) R(-)-11-hydroxyaporphine derivatives and uses thereof
IL182469A0 (en) Combination comprising zd6474 and an antiandrogen
IL178888A0 (en) Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
IL184062A0 (en) Visco-supplement composition and methods
EP1737565A4 (en) Cos-claus configurations and methods
IL180365A0 (en) Carboranylporphyrins and uses thereof
EP1797090A4 (en) Sulfonamides and uses thereof
GB0417345D0 (en) Substituted organopolysiloxanes and uses thereof
EP1786415A4 (en) Metabolism-modulating agents and uses therefor
EP1761256A4 (en) Cla-enriched milkfat and uses thereof
HK1097495A1 (en) Can body and can
EP1810976A4 (en) Benzonaphthaceneglycoside derivative and use thereof
ZA200702227B (en) Combination comprising ZD6474 and imatinib
ZA200706038B (en) Visco-supplement composition and methods